These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lysozyme as a pH-responsive valve for the controlled release of guest molecules from mesoporous silica. Xue M; Findenegg GH Langmuir; 2012 Dec; 28(50):17578-84. PubMed ID: 23173551 [TBL] [Abstract][Full Text] [Related]
4. A glucose-responsive controlled release system using glucose oxidase-gated mesoporous silica nanocontainers. Chen M; Huang C; He C; Zhu W; Xu Y; Lu Y Chem Commun (Camb); 2012 Oct; 48(76):9522-4. PubMed ID: 22903226 [TBL] [Abstract][Full Text] [Related]
6. A controlled-release nanocarrier with extracellular pH value driven tumor targeting and translocation for drug delivery. Zhao Z; Meng H; Wang N; Donovan MJ; Fu T; You M; Chen Z; Zhang X; Tan W Angew Chem Int Ed Engl; 2013 Jul; 52(29):7487-91. PubMed ID: 23757374 [TBL] [Abstract][Full Text] [Related]
7. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery. Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017 [TBL] [Abstract][Full Text] [Related]
8. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release. Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764 [TBL] [Abstract][Full Text] [Related]
10. Dual-cargo selectively controlled release based on a pH-responsive mesoporous silica system. Gui W; Wang W; Jiao X; Chen L; Wen Y; Zhang X Chemphyschem; 2015 Feb; 16(3):607-13. PubMed ID: 25492672 [TBL] [Abstract][Full Text] [Related]
11. Molecule-scale controlled-release system based on light-responsive silica nanoparticles. Wu C; Chen C; Lai J; Chen J; Mu X; Zheng J; Zhao Y Chem Commun (Camb); 2008 Jun; (23):2662-4. PubMed ID: 18535700 [TBL] [Abstract][Full Text] [Related]
12. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653 [TBL] [Abstract][Full Text] [Related]
13. A free-blockage controlled release system based on the hydrophobic/hydrophilic conversion of mesoporous silica nanopores. Wang W; Chen L; Xu LP; Du H; Wen Y; Song Y; Zhang X Chemistry; 2015 Feb; 21(6):2680-5. PubMed ID: 25504676 [TBL] [Abstract][Full Text] [Related]
14. pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles. Zhao YL; Li Z; Kabehie S; Botros YY; Stoddart JF; Zink JI J Am Chem Soc; 2010 Sep; 132(37):13016-25. PubMed ID: 20799689 [TBL] [Abstract][Full Text] [Related]
15. Enzyme-responsive supramolecular nanovalves crafted by mesoporous silica nanoparticles and choline-sulfonatocalix[4]arene [2]pseudorotaxanes for controlled cargo release. Sun YL; Zhou Y; Li QL; Yang YW Chem Commun (Camb); 2013 Oct; 49(79):9033-5. PubMed ID: 23982479 [TBL] [Abstract][Full Text] [Related]
16. Conserved Activity of Reassociated Homotetrameric Protein Subunits Released from Mesoporous Silica Nanoparticles. Deodhar GV; Adams ML; Joardar S; Joglekar M; Davidson M; Smith WC; Mettler M; Toler SA; Davies FK; Williams SKR; Trewyn BG Langmuir; 2018 Jan; 34(1):228-233. PubMed ID: 29231740 [TBL] [Abstract][Full Text] [Related]
17. Controlled release of vitamin B2 using mesoporous materials functionalized with amine-bearing gate-like scaffoldings. Bernardos A; Aznar E; Coll C; Martínez-Mañez R; Barat JM; Marcos MD; Sancenón F; Benito A; Soto J J Control Release; 2008 Nov; 131(3):181-9. PubMed ID: 18727946 [TBL] [Abstract][Full Text] [Related]
18. Hollow spherical mesoporous phosphosilicate nanoparticles as a delivery vehicle for an antibiotic drug. Das SK; Bhunia MK; Chakraborty D; Khuda-Bukhsh AR; Bhaumik A Chem Commun (Camb); 2012 Mar; 48(23):2891-3. PubMed ID: 22310528 [TBL] [Abstract][Full Text] [Related]
19. Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery. Popat A; Jambhrunkar S; Zhang J; Yang J; Zhang H; Meka A; Yu C Chem Commun (Camb); 2014 May; 50(42):5547-50. PubMed ID: 24603852 [TBL] [Abstract][Full Text] [Related]